Net sales grew 13.0% year-over-year to $6.7 billion in Q2 2026, with all segments contributing to volume and margin gains. Adjusted EBITDA rose 23.6% to $487.2 million, and net income attributable to common stockholders reached $209.0 million. Financial leverage improved to 3.0x.Original document…
Net sales grew 13.0% year-over-year to $6.7 billion in Q2 2026, with all segments contributing to volume and margin gains. Adjusted EBITDA rose 23.6% to $487.2 million, and net income attributable to common stockholders reached $209.0 million. Financial leverage improved to 3.0x.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.